-
-
-
-
-
-
-
Lexaria Bioscience Corp. Announces Closing of $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
-
-
-
-
-
-
Lexaria Attending the 27th Annual H.C. Wainwright Global Investment Conference
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Lexaria Bioscience (LEXX)
-
-
-
-
-
-
-
Lexaria Announces $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
-
-
-
-
-
-
-
Lexaria Bioscience (LEXX) Announces 1.56M Share Offering at $2.31/sh
-
-
-
-
-
22,361 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

